Rafferty Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-155,875
| Closed | -$1.04M | – | 1100 |
|
|
2025
Q1 | $1.04M | Sell |
155,875
-385
| -0.2% | -$2.57K | ﹤0.01% | 733 |
|
|
2024
Q4 | $1.96M | Buy |
156,260
+27,534
| +21% | +$346K | 0.01% | 652 |
|
|
2024
Q3 | $2.38M | Buy |
128,726
+11,081
| +9% | +$205K | 0.01% | 588 |
|
|
2024
Q2 | $2.53M | Sell |
117,645
-211,398
| -64% | -$4.55M | 0.01% | 580 |
|
|
2024
Q1 | $8.86M | Buy |
329,043
+120,538
| +58% | +$3.25M | 0.03% | 313 |
|
|
2023
Q4 | $6.25M | Sell |
208,505
-33,137
| -14% | -$993K | 0.03% | 393 |
|
|
2023
Q3 | $4.95M | Buy |
241,642
+8,558
| +4% | +$175K | 0.03% | 388 |
|
|
2023
Q2 | $4.63M | Sell |
233,084
-66,375
| -22% | -$1.32M | 0.03% | 433 |
|
|
2023
Q1 | $5.13M | Buy |
299,459
+5,498
| +2% | +$94.2K | 0.03% | 378 |
|
|
2022
Q4 | $5.75M | Buy |
293,961
+67,443
| +30% | +$1.32M | 0.05% | 346 |
|
|
2022
Q3 | $3.62M | Buy |
226,518
+139,896
| +162% | +$2.23M | 0.04% | 387 |
|
|
2022
Q2 | $1.19M | Sell |
86,622
-78,651
| -48% | -$1.08M | 0.01% | 588 |
|
|
2022
Q1 | $2.62M | Buy |
165,273
+20,866
| +14% | +$331K | 0.02% | 535 |
|
|
2021
Q4 | $3.15M | Buy |
144,407
+56,213
| +64% | +$1.23M | 0.02% | 525 |
|
|
2021
Q3 | $2.64M | Buy |
88,194
+31,707
| +56% | +$948K | 0.02% | 548 |
|
|
2021
Q2 | $2.5M | Sell |
56,487
-5,646
| -9% | -$250K | 0.02% | 598 |
|
|
2021
Q1 | $2.76M | Buy |
62,133
+55,163
| +791% | +$2.45M | 0.02% | 541 |
|
|
2020
Q4 | $382K | Sell |
6,970
-29,852
| -81% | -$1.64M | ﹤0.01% | 748 |
|
|
2020
Q3 | $842K | Buy |
36,822
+21,975
| +148% | +$502K | 0.01% | 599 |
|
|
2020
Q2 | $311K | Buy |
+14,847
| New | +$311K | ﹤0.01% | 819 |
|
|
2020
Q1 | – | Sell |
-15,783
| Closed | -$359K | – | 761 |
|
|
2019
Q4 | $359K | Sell |
15,783
-25,198
| -61% | -$573K | 0.01% | 753 |
|
|
2019
Q3 | $477K | Sell |
40,981
-3,734
| -8% | -$43.5K | 0.01% | 668 |
|
|
2019
Q2 | $671K | Buy |
44,715
+13,792
| +45% | +$207K | 0.01% | 635 |
|
|
2019
Q1 | $542K | Buy |
+30,923
| New | +$542K | 0.01% | 654 |
|